Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 09:44 am Purchase | 2024-12-31 | 13G | IGM Biosciences, Inc. IGMS | T. Rowe Price Associates, Inc. | 3,568,999 10.500% | 3,503,059 (+5312.49%) | Filing History |
| 2025-02-07 11:55 am Sale | 2025-01-31 | 13G | IGM Biosciences, Inc. IGMS | T. Rowe Price Associates, Inc. | 65,940 0.200% | -3,948,319 (-98.36%) | Filing History |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | IGM Biosciences, Inc. IGMS | T. Rowe Price Associates, Inc. | 4,014,259 11.800% | 610,545 (+17.94%) | Filing History |
| 2024-11-12 10:32 am Sale | 2024-11-08 | 13G | IGM Biosciences, Inc. IGMS | FMR LLC | 819,529 2.415% | -878,977 (-51.75%) | Filing History |
| 2024-08-02 6:41 pm Purchase | 2024-07-25 | 13G | IGM Biosciences, Inc. IGMS | Invus Public Equities, L.P. | 3,330,422 9.900% | 3,330,422 (New Position) | Filing History |
| 2024-03-28 7:13 pm Purchase | 2024-03-28 | 13D | IGM Biosciences, Inc. IGMS | Baker Bros. Advisors LP | 4,145,706 12.400% | 401,037 (+10.71%) | Filing History |
| 2024-02-12 10:07 am Purchase | 2024-01-31 | 13G | IGM Biosciences, Inc. IGMS | T. Rowe Price Associates, Inc. | 3,403,714 10.300% | 141,505 (+4.34%) | Filing History |
| 2024-02-12 10:03 am Purchase | 2023-12-31 | 13G | IGM Biosciences, Inc. IGMS | T. Rowe Price Associates, Inc. | 3,262,209 9.900% | 1,055,802 (+47.85%) | Filing History |
| 2024-02-09 5:11 pm Purchase | 2023-12-31 | 13G | IGM Biosciences, Inc. IGMS | Artal Participations S.a r.l | 3,100,422 9.400% | 650,422 (+26.55%) | Filing History |
| 2024-02-09 09:16 am Purchase | 2024-02-08 | 13G | IGM Biosciences, Inc. IGMS | FMR LLC | 1,698,506 5.163% | 1,698,506 (New Position) | Filing History |
| 2023-12-15 5:20 pm Purchase | 2023-12-15 | 13D | IGM Biosciences, Inc. IGMS | Baker Bros. Advisors LP | 3,744,669 11.400% | 467,102 (+14.25%) | Filing History |
| 2023-07-19 4:13 pm Sale | 2023-06-26 | 13D | IGM Biosciences, Inc. IGMS | Topsoe Holding A/S | 10,543,303 32.200% | -2,194,091 (-17.23%) | Filing History |
| 2023-06-28 5:15 pm Purchase | 2023-06-26 | 13D | IGM Biosciences, Inc. IGMS | Redmile Group LLC | 3,291,092 9.900% | 257,595 (+8.49%) | Filing History |
| 2023-06-28 5:01 pm Purchase | 2023-06-22 | 13D | IGM Biosciences, Inc. IGMS | Baker Bros. Advisors LP | 3,277,567 9.990% | 107,673 (+3.40%) | Filing History |
| 2023-06-13 5:15 pm Sale | 2023-06-12 | 13D | IGM Biosciences, Inc. IGMS | Redmile Group LLC | 3,033,497 10.300% | -343,593 (-10.17%) | Filing History |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | IGM Biosciences, Inc. IGMS | T. Rowe Price Associates, Inc. | 2,206,407 7.600% | -164,868 (-6.95%) | Filing History |
| 2023-02-10 7:28 pm Purchase | 2023-02-10 | 13G | IGM Biosciences, Inc. IGMS | Artal Participations S.a r.l | 2,450,000 8.400% | 950,000 (+63.33%) | Filing History |
| 2022-10-05 5:00 pm Purchase | 2022-10-03 | 13D | IGM Biosciences, Inc. IGMS | Redmile Group LLC | 3,377,090 11.600% | 14,630 (+0.44%) | Filing History |
| 2022-04-05 5:15 pm Purchase | 2022-03-29 | 13D | IGM Biosciences, Inc. IGMS | Baker Bros. Advisors LP | 3,169,894 11.600% | 12,110 (+0.38%) | Filing History |
| 2022-04-05 5:09 pm Sale | 2022-04-01 | 13D | IGM Biosciences, Inc. IGMS | Redmile Group LLC | 3,362,460 12.900% | -75,572 (-2.20%) | Filing History |